Health Condition 1: K053- Chronic periodontitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Generalized Gingivitis Patient: Individual with at least 20 remaining teeth with: Gingival index > 20% Bleeding on probing > 20% of sites Probing depth Clinical attachment loss Generalized Chronic Periodontitis Patient Individual with at least 20 remaining teeth with: Gingival Index >20% Bleeding on Probing > 20% Probing Depth > 4mm Clinical Attachment Loss >= 1mm
Exclusion criteria
Exclusion criteria: Any periodontal surgery in the past 6 months. Any chronic diseases, infectious diseases, immunological diseases, pregnancy, lactation, smoking (current or former smoker for 10 years). Use of medications such as: antibiotics, anti-inflammatory drugs, steroids, immunosuppressants, anticoagulants, and lipid-lowering drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effectiveness of salivary myeloperoxidase as a marker of periodontal disaeseTimepoint: 1 month and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| All the clinical parameters along with the MPO level will be assessed at baseline in Gingivitis and Chronic Periodontitis patients. Then after non-surgical periodontal therapy these parameters along with the MPO levels will be assessed again after 1 month and after 3 monthsTimepoint: 1 month and 3 months | — |
Countries
India
Contacts
Sudha Rustagi College of Dental Science and Research